Transverse myelitis screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Transverse myelitis}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR Accordin...") |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for transverse myelitis. | ||
==References== | ==References== | ||
Latest revision as of 07:37, 21 April 2020
|
Transverse myelitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Transverse myelitis screening On the Web |
|
American Roentgen Ray Society Images of Transverse myelitis screening |
|
Risk calculators and risk factors for Transverse myelitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for transverse myelitis.